Todd Luman

Q: What is Todd Luman email address?

Email Todd Luman at todd.luman@allogene.com. This email is the most updated Todd Luman email found in 2026.

Q: How to contact Todd Luman?

To contact Todd Luman send an email to todd.luman@allogene.com. If you want to call Todd Luman try calling on +18057945579 and +15102846073.

Executive Director Process Sciences at Allogene Therapeutics | San Francisco Bay Area

About Todd Luman

Todd Luman serves as the Executive Director of Process Sciences at Allogene Therapeutics, where he plays a pivotal role in advancing the development of innovative CAR-T therapies. With a robust background in biopharmaceuticals and biotechnology, Todd leads cross-functional teams through critical phases of process development, from First-In-Human trials to pivotal studies. His expertise in mammalian cell culture, particularly within the realms of biologics and cell therapy, enables him to effectively navigate the complexities of drug substance development.

At Allogene, Todd oversees several key projects that focus on early and late-stage process development and characterization of CAR-T products. He is responsible for the Drug Substance teams, which include bench-scale teams dedicated to scale-down model development, process characterization studies, and pilot-scale teams that emphasize scale-up and technology transfer. His leadership is instrumental in building the necessary infrastructure and capabilities for new process development cell culture facilities, ensuring that Allogene remains at the forefront of cell therapy innovation.

Todd's strategic planning and problem-solving skills are complemented by his extensive knowledge of FDA regulations and GMP practices, which are crucial for maintaining compliance and ensuring product quality. His commitment to excellence in protein purification and validation processes further enhances the reliability of the therapies developed under his guidance. With a focus on collaboration and tactical execution, Todd Luman exemplifies the leadership necessary to drive Allogene Therapeutics' mission of delivering transformative therapies to patients in need.

Todd Luman Work